Skip to content

Effect of Smart Phone Application on the Individualized Management of Chinese Diabetic Patients

Individualized Management Based on Mobile Phone Platform in Diabetic Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02589730
Enrollment
234
Registered
2015-10-28
Start date
2015-10-31
Completion date
2016-10-31
Last updated
2015-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Smartphone app, diabetic management, lifestyle behaviors, medication management

Brief summary

The purpose of this study was to explore a model suitable for the individualized diabetic management based on the mobile application coaching and demonstrate its effect among the diabetic mellitus population.

Detailed description

The enrolled patients will be randomly divided into three groups: group of online self management, group of online mutual management and the control group. The estimated sample size was 78 patients for each group. All the patients attend two follow-up visits at the hospital, after 3 and 6 months. The data will be collected by a full-time recorder and analyzed using specific statistical software. The enumeration data are analyzed by chi-square test, while the measurement data are analyzed by one-way ANOVA.

Interventions

DEVICEWelltang App

This App is a large platform of individualized diabetic management

Sponsors

Shanghai Geping Information Technology Company
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Physician diagnosis of DM for more than 6 months; * Glycated hemoglobin more than or equal to 8% within 3 months; * Age:18-65 years.

Exclusion criteria

* Insulin pump users; * Pregnant; * Active substance, alcohol, or drug abuser; * Psychotic or schizophrenic under active care; * Severe hearing or visual impairment and other complications; * Drug users (such as glucocorticoid or thyroid hormone) 3 months before the enrollment; * No smartphone access.

Design outcomes

Primary

MeasureTime frame
change in glycated hemoglobin levelssix months

Secondary

MeasureTime frame
change of urinary albumin creatinine ratesix months
change in lipid profile levelssix months
change of hepatic functionsix months
change of blood creatinesix months
change of blood urea nitrogensix months
change in scores measured by MKTsix months

Other

MeasureTime frame
change in scores measured by Moriskysix months
change in scores measured by self distress scalesix months
change in scores measured by self anxiety scalesix months
change in scores measured by DES-SFsix months
change in scores measured by SDSCAsix months

Countries

China

Contacts

Primary ContactLei Zhang, MM
stonez78@hotmail.com+86-18930173806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026